Health officials have issued a timely advisory concerning the potential reduced effectiveness of life-saving medications in the UK during the current heatwave with temperatures reaching 37C. Insulin pens, weight-loss injections, and asthma inhalers are among the prescribed drugs that should be stored at cool temperatures below 30C when not refrigerated.

In hot weather conditions, medications left in bags, on windowsills, or in vehicles can quickly heat up, leading to compromised efficacy when used later. Exposure to direct sunlight or high temperatures can significantly degrade insulin protein, resulting in decreased potency and elevated blood glucose levels in Type 1 Diabetics. Similarly, overheating can alter the chemical composition of asthma inhalers, rendering them ineffective during asthma attacks. Prolonged exposure to heat can also weaken weight-loss drugs like Wegovy and Mounjaro.

Alison Cave, Chief Safety Officer at the MHRA, emphasized the importance of storing medications properly during heatwaves to maintain their effectiveness. She highlighted the risks associated with improper medication storage in hot environments, especially for individuals with conditions like asthma, heart disease, or diabetes.

The London Ambulance Service reported a record number of life-threatening emergencies, attributing the surge to the extreme heat. Ambulance crews responded to 642 category one calls on Wednesday, which include critical incidents like cardiac arrests. Chief executive Jason Killens acknowledged the exceptional efforts of the crews in challenging conditions and urged the public to take precautions, such as avoiding excessive sun exposure and staying hydrated.

As the region grapples with the effects of the heatwave, it is crucial for individuals to be mindful of medication storage and personal well-being during hot weather conditions.